Skip to main content
. 2022 Feb 25;13:846384. doi: 10.3389/fimmu.2022.846384

Figure 6.

Figure 6

HSC inhibits the activation of TAK1 via PIP2. RAW264.7 (A), THP-1 (B) cells treated with HSC for 4 h, and then induced by LPS (1 μg/ml) for 1 h; The collected proteins were immunoprecipitated with PIP2 using magnetic beads, and immunocomplexes were determined by western blotting; ### P < 0.001 compared to control alone group; *** P < 0.001 versus the LPS group, (n=3).